Celix Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 10.00 K
- Company Age 7 Months 7 Days
About Celix Pharmaceuticals (India)
Celix Pharmaceuticals (India) Private Limited (CPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 July 2024 ( seven months 7 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Subramanian Vasudevan and Shantreddy Soogareddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U46497TS2024PTC187646
- Company No.
187646
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Who are the key members and board of directors at Celix Pharmaceuticals (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramanian Vasudevan  | Director | 18-Jul-2024 | Current |
| Shantreddy Soogareddy | Director | 18-Jul-2024 | Current |
Financial Performance of Celix Pharmaceuticals (India).
Enhance accessibility to Celix Pharmaceuticals (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Celix Pharmaceuticals (India)?
Unlock access to Celix Pharmaceuticals (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Malladi Drugs And Pharmaceuticals LimitedSubramanian Vasudevan is a mutual person
Hxco India Private LimitedSubramanian Vasudevan is a mutual person
Sandor Life Sciences Private LimitedSubramanian Vasudevan is a mutual person
Vishar Portfolio Investment Pvt LtdSubramanian Vasudevan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Celix Pharmaceuticals (India)?
Unlock and access historical data on people associated with Celix Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Celix Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celix Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.